BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 38180)

  • 1. Correlations between clinical, blood leukocyte, and skin test data in the National Cooperative Crohn's Disease Study.
    Beeken WL; Sessions JT; Bozymski EM
    Gastroenterology; 1979 Oct; 77(4 Pt 2):921-4. PubMed ID: 38180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cooperative Crohn's Disease Study: results of drug treatment.
    Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
    Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
    Singleton JW; Law DH; Kelley ML; Mekhjian HS; Sturdevant RA
    Gastroenterology; 1979 Oct; 77(4 Pt 2):870-82. PubMed ID: 38177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine-related pancreatitis in patients with Crohn's disease.
    Sturdevant RA; Singleton JW; Deren JL; Law DH; McCleery JL
    Gastroenterology; 1979 Oct; 77(4 Pt 2):883-6. PubMed ID: 38178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The National Cooperative Crohn's Disease Study.
    MacLean LD
    Can J Surg; 1980 Jan; 23(1):7-8. PubMed ID: 6102492
    [No Abstract]   [Full Text] [Related]  

  • 6. National Cooperative Crohn's Disease Study: study design and conduct of the study.
    Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
    Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease.
    Gyte GM; Willoughby JM
    Clin Exp Immunol; 1977 Nov; 30(2):242-51. PubMed ID: 342153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Crohn's disease with azathioprine: a controlled evaluation.
    Klein M; Binder HJ; Mitchell M; Aaronson R; Spiro H
    Gastroenterology; 1974 May; 66(5):916-22. PubMed ID: 4597093
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
    Singleton JW
    Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the course of Crohn's disease under Imurel treatment].
    Fehr HF
    Z Gastroenterol; 1974 Dec; 12(8):595-6. PubMed ID: 4155179
    [No Abstract]   [Full Text] [Related]  

  • 11. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selected cellular immunity parameters in patients with Lesniowski-Crohn disease].
    Słotwiński R; Szczygieł B; Lech G; Kolewska D; Wasik M
    Pol Merkur Lekarski; 1997 Nov; 3(17):224-7. PubMed ID: 9523477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 15. [T-lymphocyte subpopulations in the peripheral blood of patients with Crohn disease].
    Purrmann J; Hengels KJ; Cleveland S; Gemsa R; Koldehoff M; Strohmeyer G
    Z Gastroenterol; 1990 May; 28(5):242-6. PubMed ID: 2144933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG treatment of Crohn's disease.
    Rahban S; Sherman JH; Opelz G; Conley DR; Panish JF; Marks JW; Terasaki PI; Schoenfield LJ
    Am J Gastroenterol; 1979 Feb; 71(2):196-201. PubMed ID: 373425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Effect of azathioprine and cell-mediated immunity in Crohn's disease.
    Willoughby JM; Gyte GM
    Gut; 1976 May; 17(5):399. PubMed ID: 1278766
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of azathioprine in nine children with Crohn's disease.
    Shah MD; Berman WF
    Va Med Q; 1991; 118(3):169-70. PubMed ID: 1678282
    [No Abstract]   [Full Text] [Related]  

  • 19. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications.
    Rankin GB; Watts HD; Melnyk CS; Kelley ML
    Gastroenterology; 1979 Oct; 77(4 Pt 2):914-20. PubMed ID: 467943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of peripheral lymphocytes in the prediction of recurrence in Crohn's disease.
    Heimann TM; Aufses AH
    Surg Gynecol Obstet; 1985 Apr; 160(4):295-8. PubMed ID: 3983792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.